INSULET CORP (PODD)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NASDAQ
$151.51
+2.35%
Investingg Score
51.1 / 100
Hold
Business overview
- Gross margin of 71.6%
- Operating margin of 17.5%
These high margins reflect solid core profitability in the surgical and medical instruments sector, though earnings pressures remain.
Financial health
- Free cash flow margin of 13.9%
- Balance sheet score of 56 and risk score of 80
These metrics indicate steady cash generation alongside moderate financial risk.
- Gross Margin
- 71.6%
- Operating Margin
- 17.5%
- Current Ratio
- 2.8x
- Debt / Equity
- Data unavailable
- Free Cash Flow (TTM)
- $0.4B
- Interest Coverage
- 8x
Valuation
- P/E ratio of 36.01
- Forward P/E of 22.64
- P/S ratio of 3.65
- FCF yield of 3.5%
These multiples suggest that the stock's valuation improves on a forward-looking basis as earnings catch up.
- P/E (TTM)
- 36.0x
- Forward P/E
- 22.6x
- Price / Sales
- 3.6x
- EV / EBITDA
- Data unavailable
- FCF Yield
- 3.5%
Key risks
- Year-over-year EPS decline of 39.8% indicates persistent profitability headwinds.
- Stock is in a clear Downtrend with the price 31.4% below the 200-day SMA.
- Overall Investingg score of 51.1 and Hold verdict reflect a balanced risk profile.
Market cap $10.7B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze PODD with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.